↓ Skip to main content

Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled study

Overview of attention for article published in BMC Gastroenterology, November 2014
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
35 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled study
Published in
BMC Gastroenterology, November 2014
DOI 10.1186/1471-230x-14-188
Pubmed ID
Authors

Philip B Miner, Debra G Silberg, Magnus Ruth, Frank Miller, John Pandolfino

Abstract

The gamma-aminobutyric acid type B-receptor agonist lesogaberan (AZD3355) has been developed for use in patients with gastroesophageal reflux disease (GERD) symptoms despite proton pump inhibitor (PPI) therapy (partial responders). This study aimed to explore the dose-response effect of lesogaberan on reflux episodes in partial responders.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 35 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 17%
Student > Ph. D. Student 4 11%
Unspecified 3 9%
Researcher 3 9%
Student > Doctoral Student 2 6%
Other 4 11%
Unknown 13 37%
Readers by discipline Count As %
Medicine and Dentistry 10 29%
Unspecified 3 9%
Chemistry 2 6%
Psychology 2 6%
Nursing and Health Professions 1 3%
Other 4 11%
Unknown 13 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 November 2014.
All research outputs
#20,245,139
of 22,772,779 outputs
Outputs from BMC Gastroenterology
#1,361
of 1,743 outputs
Outputs of similar age
#303,350
of 362,502 outputs
Outputs of similar age from BMC Gastroenterology
#20
of 26 outputs
Altmetric has tracked 22,772,779 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,743 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,502 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.